Page last updated: 2024-09-05

lapatinib and bms201038

lapatinib has been researched along with bms201038 in 1 studies

Compound Research Comparison

Studies (lapatinib)	Trials (lapatinib)	Recent Studies (post-2010) (lapatinib)	Studies (bms201038)	Trials (bms201038)	Recent Studies (post-2010) (bms201038)
1,919	305	1,442	128	13	106

Protein Interaction Comparison

Protein	Taxonomy	lapatinib (IC50)	bms201038 (IC50)
Delta-type opioid receptor	Mus musculus (house mouse)		0.0008
Microsomal triglyceride transfer protein large subunit	Homo sapiens (human)		0.0056

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Combrinck, JM; de Sousa, ACC; Egan, TJ; Maepa, K	1

Other Studies

1 other study(ies) available for lapatinib and bms201038

Article	Year
Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites. Molecules (Basel, Switzerland), 2020, Mar-29, Volume: 25, Issue:7 Topics: Antimalarials; Benzimidazoles; Binding Sites; Chloroquine; Drug Repositioning; Drug Resistance; Erythrocytes; Hemeproteins; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Lapatinib; Molecular Docking Simulation; Plasmodium falciparum; Pyrimethamine; Pyrimidines; Thermodynamics	2020

Article

Year

Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.

Molecules (Basel, Switzerland), 2020, Mar-29, Volume: 25, Issue:7

Topics: Antimalarials; Benzimidazoles; Binding Sites; Chloroquine; Drug Repositioning; Drug Resistance; Erythrocytes; Hemeproteins; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Lapatinib; Molecular Docking Simulation; Plasmodium falciparum; Pyrimethamine; Pyrimidines; Thermodynamics

2020